Search Results - "Fernández Jiménez, Dolores"
-
1
Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain—The Fostasur Study
Published in British journal of haematology (01-05-2024)“…Summary Immune thrombocytopenia (ITP) is characterized by low platelet counts (PLTs) and an increased risk of bleeding. Fostamatinib, a spleen tyrosine kinase…”
Get full text
Journal Article -
2
Platelet Responses After Tapering and Discontinuation of Fostamatinib in Patients with Immune Thrombocytopenia: A Continuation of the Fostasur Study
Published in Journal of clinical medicine (01-11-2024)“…Background/objectives: Fostamatinib is a spleen tyrosine kinase (SYK) inhibitor approved for the treatment of adult patients with chronic immune…”
Get full text
Journal Article -
3
Treatment and complications in acquired hemophilia A. Experience from a single center
Published in Medicina clinica (22-11-2017)Get more information
Journal Article -
4
Treatment and complications in acquired hemophilia A. Experience from a single center
Published in Medicina clínica (English ed.) (22-11-2017)Get full text
Journal Article -
5
Validation of a Portable Coagulometer for Routine In-Hospital Use for Newborns
Published in Pediatric critical care medicine (01-11-2017)“…To verify the reliability and clinical benefits of the coagulation tests made by a point of care device in newborn admitted to a neonatal unit. We made a…”
Get full text
Journal Article -
6
Toxicidad mucocutánea por tratamientos con hidroxiurea de larga duración
Published in Piel (01-10-2017)Get full text
Journal Article -
7
Efficacy and Safety of Fostamatinib for Immune Thrombocytopenia in Clinical Practice in Spain: Interim Results of Fostames, Our National Fostamatinib Registry
Published in Blood (02-11-2023)“…Background: Fostamatinib is a splenic tyrosine kinase (SYK) inhibitor that prevents antibody-mediated platelet destruction. This drug has demonstrated to be…”
Get full text
Journal Article -
8
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice
Published in Blood (08-08-2024)“…•Similar to clinical trial results, fostamatinib has demonstrated a high efficacy rate for ITP in daily clinical practice conditions.•Fostamatinib is a…”
Get full text
Journal Article